Evidence map›Paper›PMID 39925428›Full record

ArticleiScience2025

DPANN symbiont of

Oleg N Reva, Violetta La Cono, Laura Marturano, Francesca Crisafi, Francesco Smedile, Manasi Mudaliyar, Debnath Ghosal, Elena A Selivanova, Marina E Ignatenko, Manuel Ferrer and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Oleg N RevaDepartment of Biochemistry, Genetics and Microbiology, Centre for Bioinformatics and Computational Biology, University of Pretoria, 0002 Pretoria, South Africa.
Violetta La ConoExtreme Microbiology, Biotechnology and Astrobiology Group, Institute of Polar Sciences, ISP-CNR, 98122 Messina, Italy.
Laura MarturanoExtreme Microbiology, Biotechnology and Astrobiology Group, Institute of Polar Sciences, ISP-CNR, 98122 Messina, Italy.
Francesca CrisafiExtreme Microbiology, Biotechnology and Astrobiology Group, Institute of Polar Sciences, ISP-CNR, 98122 Messina, Italy.
Francesco SmedileExtreme Microbiology, Biotechnology and Astrobiology Group, Institute of Polar Sciences, ISP-CNR, 98122 Messina, Italy.
Manasi MudaliyarDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, 3052 VIC, Australia.
Debnath GhosalDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, 3052 VIC, Australia.
Elena A SelivanovaOrenburg Federal Research Center, Institute for Cellular and Intracellular Symbiosis, Ural Branch of Russian Academy of Sciences, 460000 Orenburg, Russia.
Marina E IgnatenkoOrenburg Federal Research Center, Institute for Cellular and Intracellular Symbiosis, Ural Branch of Russian Academy of Sciences, 460000 Orenburg, Russia.
Manuel FerrerInstituto de Catalisis y Petroleoquimica (ICP), CSIC, 28049 Madrid, Spain.
Laura Fernandez-LopezInstituto de Catalisis y Petroleoquimica (ICP), CSIC, 28049 Madrid, Spain.
Mart KrupovicInstitut Pasteur, Université Paris Cité, CNRS UMR6047, Archaeal Virology Unit, 75015 Paris, France.
Michail M YakimovExtreme Microbiology, Biotechnology and Astrobiology Group, Institute of Polar Sciences, ISP-CNR, 98122 Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines a natural consortium of halophilic archaea, comprising xylan-degrading

Indexed as

BiochemistryEnvironmental BiotechnologyMicrobiology

Identifiers

PMID39925428
PMCPMC11803251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.